(Q36789118)

16 August 2017

1 reference

title

Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media (English)

1 reference

16 August 2017

Carlo Bartolozzi

1

1 reference

16 August 2017

Laura Crocetti

2

1 reference

16 August 2017

Riccardo Lencioni

3

1 reference

16 August 2017

Dania Cioni

4

1 reference

16 August 2017

Clotilde Della Pina

5

1 reference

16 August 2017

Daniela Campani

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

16 February 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

17

1 reference

16 August 2017

issue

10

1 reference

16 August 2017

page(s)

2519-2530

1 reference

https://scigraph.springernature.com/pub.10.1007/s00330-007-0602-5

16 August 2017

exact match

0 references

cites work

Contrast agents for MR imaging of the liver

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0602-5

Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0602-5

Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0602-5

MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0602-5

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0602-5

Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0602-5

Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0602-5

Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-007-0602-5

Multihance clinical pharmacology: biodistribution and MR enhancement of the liver

21 January 2018

1 reference

12 December 2020

Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.

1 reference

12 December 2020

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

12 December 2020

Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia

1 reference

12 December 2020

Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging

1 reference

12 December 2020

Subdivision of hexagonal liver lobules into a structural and functional unit; role in hepatic physiology and pathology

1 reference

12 December 2020

Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization

1 reference

12 December 2020

Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study

1 reference

12 December 2020

Hepatic transport of gadobenate dimeglumine in TR-rats

1 reference

12 December 2020

Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography

1 reference

12 December 2020

Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology

1 reference

12 December 2020

Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications

1 reference

12 December 2020

Preneoplastic lesions in human hepatocarcinogenesis

1 reference

12 December 2020

Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging

1 reference

12 December 2020

Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning

1 reference

12 December 2020

1 reference

12 December 2020

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

1 reference

12 December 2020

Evaluation of the Accuracy of Gadobenate Dimeglumine-Enhanced MR Imaging in the Detection and Characterization of Focal Liver Lesions

1 reference

12 December 2020

Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver

1 reference

12 December 2020

Kupffer-cell depletion in chronic liver disease: implications for hepatic carcinogenesis

1 reference

12 December 2020

Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging

1 reference

12 December 2020

Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging

1 reference

12 December 2020

An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.

1 reference

12 December 2020

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

1 reference

12 December 2020

Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments

1 reference

12 December 2020

Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study

1 reference

12 December 2020

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

12 December 2020

Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.

1 reference

12 December 2020

Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma

1 reference

12 December 2020

Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images

1 reference

12 December 2020

Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging

1 reference

12 December 2020

Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions

1 reference

12 December 2020

Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis

1 reference

12 December 2020

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging

1 reference

12 December 2020

Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver

1 reference

12 December 2020

Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.

1 reference

12 December 2020

Mn-DPDP enhancement patterns of hepatocellular lesions on MR images

1 reference

12 December 2020

MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis

1 reference

12 December 2020

Gadobenate dimeglumine (Gd-BOPTA). An overview

1 reference

12 December 2020

The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization

1 reference

12 December 2020

Magnetic resonance imaging of liver tumors

1 reference

12 December 2020

Preneoplastic cellular changes in liver

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience

1 reference

12 December 2020

Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.

1 reference

12 December 2020

Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications

1 reference

12 December 2020

Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors

1 reference

12 December 2020

Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number

1 reference

12 December 2020

MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties

1 reference

12 December 2020

Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)

1 reference

12 December 2020

Digestive and liver diseases statistics, 2004.

1 reference

12 December 2020

Terminology of nodular hepatocellular lesions.

1 reference

12 December 2020

Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma.

1 reference

12 December 2020

Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.

1 reference

12 December 2020

Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging

1 reference

12 December 2020

The unit-concept of hepatic parenchyma--a re-examination based on angioarchitectural studies

1 reference

12 December 2020

Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP)

1 reference

12 December 2020

Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging.

1 reference

12 December 2020

Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA

1 reference

12 December 2020

Macroregenerative (dysplastic) nodules and hepatocarcinogenesis: theoretical and clinical considerations

1 reference

12 December 2020

Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading

1 reference

12 December 2020

Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations

1 reference

12 December 2020

Management of hepatocellular carcinoma

1 reference

12 December 2020

Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.

1 reference

12 December 2020

Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors

1 reference

12 December 2020

10.1007/S00330-007-0602-5

Identifiers

DOI

1 reference

16 August 2017

1 reference